EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Digitally enhanced ketogenic diet versus low‐fat diet for cardio‐renal‐metabolic health in a predominantly Hispanic adult population with overweight or obesity: Pilot randomised clinical trial

Yan Du iD, Jing Wang, Shiyu Li, Christiane Meireles, Afaf Saliba, Alondra Castillo, Martin Goros, Johnathan Gelfond, Byeong Yeob Choi, Lu Qi iD, Chengdong Li, Kumar Sharma

Diabetes, Obesity and Metabolism · 2025-11 · 27 (11) · 6154-6166

DOI: 10.1111/dom.70000 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 06.08.2025. Verfasst von Yan Du und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing, UT Health at San Antonio, San Antonio, Texas, USA. Hauptthemen laut MEDLINE: Diet, Fat-Restricted, Diet, Ketogenic, Obesity, Overweight. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH National Center for Advancing Translational Sciences, NCATS NIH HHS, San Antonio Older Americans Independence Center Mentored Research Career Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Individuals respond differently to diets for weight loss and cardio–renal–metabolic health. Advances in digital health and metabolomics hold promise for personalised lifestyle interventions. The study evaluated the feasibility and the preliminary efficacy of a digitally enhanced ketogenic diet compared with a low‐fat diet, and explored the potential to use metabolites to guide personalised lifestyle interventions via digital health tools. Materials and Methods The study randomised 60 adults living with overweight or obesity to a ketogenic diet ( n = 30) or a low‐fat diet ( n = 30). Both groups received digital lifestyle interventions, including digitally delivered education sessions, mobile and wearable devices to monitor lifestyle behaviour and health indicators, and weekly individualised feedback through digital communication platforms. Clinical outcomes (e.g., weight, blood pressure (BP), HbA1c) and targeted metabolites were collected at baseline, 3 and 6 months. Intention‐to‐treat analysis and linear mixed models were used to assess group and time differences.

Results

The study successfully enrolled the planned sample size ( N = 60) within 1 year despite COVID‐19‐related challenges. Retention rates were 73.3% at 3 months and 71.7% at 6 months. Participants were 58.3% Hispanic. No significant differences in clinical or metabolic outcomes were observed between the groups, except that the ketogenic group had significantly higher ketone levels than the low‐fat group at 3 months ( b = 0.2, 95% CI = [0.05, 0.35], p = 0.015). Both groups showed significant weight and Body Mass Index reductions at 3 and 6 months. HbA1c improved only in the ketogenic group (baseline: 6.0 ± 0.9%; 3‐month: 5.5 ± 0.7%, p < 0.001; 6‐month: 5.7 ± 0.8%, p = 0.004), and systolic blood pressure (BP) improved in the ketogenic group at 3 months (131.2 ± 12.9 to 123.1 ± 11.2, p = 0.006). Most targeted metabolites (e.g., isoleucine, leucine) decreased significantly from baseline to 3‐ (~21/29 metabolites) and 6‐month (~22/29 metabolites) within both groups.

Conclusions

Digitally enhanced lifestyle intervention was feasible. Both diets, enhanced by digital tools, were efficacious in weight reduction. The ketogenic diet showed potential benefits for glycaemic and BP control. Metabolite changes reflect sensitive responses to lifestyle interventions. Further research is warranted to explore the integration of digital tools and metabolic data for developing personalised lifestyle interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diet, Fat-RestrictedDiet, KetogenicObesityOverweightAdultFemaleHumansMaleMiddle AgedBlood PressureHispanic or LatinoPilot ProjectsTelemedicineWeight Loss

Stichwörter der Autor:innen

clinical trialdietary interventiontype 2 diabetesweight control

Autor:innen und Institutionen

  • School of Nursing, UT Health at San Antonio, San Antonio, Texas, USA.
  • College of Nursing, Florida State University, Tallahassee, Florida, USA.
  • School of Kinesiology, Louisiana State University, Baton Rouge, Louisiana, USA.
  • Center for Precision Medicine, School of Medicine, UT Health at San Antonio, San Antonio, Texas, USA.
  • Waco Family Medicine, Waco, Texas, USA.
  • Department of Population Health Sciences, School of Medicine, UT Health at San Antonio, San Antonio, Texas, USA.

ORCID-Profile: Yan Du, Lu Qi

Förderung

  • NIH National Center for Advancing Translational Sciences
  • NCATS NIH HHS
  • San Antonio Older Americans Independence Center Mentored Research Career Development Program
  • NIA NIH HHS
  • The 80/20 Foundation

Zitieren

APA

Du, Y., Wang, J., Li, S., Meireles, C., Saliba, A., Castillo, A., Goros, M., Gelfond, J., Choi, B. Y., Qi, L., Li, C., & Sharma, K. (2025). Digitally enhanced ketogenic diet versus low‐fat diet for cardio‐renal‐metabolic health in a predominantly Hispanic adult population with overweight or obesity: Pilot randomised clinical trial. Diabetes, Obesity and Metabolism, 27(11), 6154-6166. https://doi.org/10.1111/dom.70000

Vancouver

Du Y, Wang J, Li S, Meireles C, Saliba A, Castillo A, et al. Digitally enhanced ketogenic diet versus low‐fat diet for cardio‐renal‐metabolic health in a predominantly Hispanic adult population with overweight or obesity: Pilot randomised clinical trial. Diabetes, Obesity and Metabolism. 2025;27(11):6154-6166. doi:10.1111/dom.70000

BibTeX
@article{Du2025,
  author = {Du, Yan and Wang, Jing and Li, Shiyu and Meireles, Christiane and Saliba, Afaf and Castillo, Alondra and Goros, Martin and Gelfond, Johnathan and Choi, Byeong Yeob and Qi, Lu and Li, Chengdong and Sharma, Kumar},
  title = {Digitally enhanced ketogenic diet versus low‐fat diet for cardio‐renal‐metabolic health in a predominantly Hispanic adult population with overweight or obesity: Pilot randomised clinical trial},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2025},
  volume = {27},
  number = {11},
  pages = {6154--6166},
  doi = {10.1111/dom.70000}
}
Kostenlos starten →